Rech J, Tascilar K, Hagen M, Kleyer A, Manger B, Schoenau V, Hueber AJ, Kleinert S, Baraliakos X, Braun J, Kiltz U, Fleck M, Rubbert-Roth A, Kofler DM, Behrens F, Feuchtenberger M, Zaenker M, Voll R, Venhoff N, Thiel J, Glaser C, Feist E, Burmester GR, Karberg K, Strunk J, Cañete JD, Senolt L, Filkova M, Naredo E, Largo R, Krönke G, D'Agostino MA, Østergaard M, Schett G.
Abatacept inhibits inflammation and onset of rheumatoid arthritis in individuals at high risk (ARIAA): a randomised, international, multicentre, double-blind, placebo-controlled trial.
Lancet. 2024 Mar 2;403(10429):850-859. doi: 10.1016/S0140-6736(23)02650-8. Epub 2024 Feb 13. PMID: 38364841.
Butter L, Haase-Fielitz A, Zänker M, Becher G, Nübel J, Butter C.
Cluster analysis of volatile organic compounds - A pilot study in patients with severe acute decompensated heart failure.
J Cardiol. 2024 Aug;84(2):146-148. doi: 10.1016/j.jjcc.2024.04.003. Epub 2024 Apr 15. PMID: 38621579.
Takase-Minegishi K, Böhringer S, Nam JL, Kaneko Y, Behrens F, Saevarsdottir S, Detert J, Leirisalo-Repo M, van der Heijde D, Landewé R, Ramiro S, van der Woude D.
The impact of autoantibodies on the efficacy of biological disease-modifying anti-rheumatic drugs in rheumatoid arthritis: meta-analysis of randomized controlled trials.
Rheumatology (Oxford). 2024 Feb 16:keae113. doi:10.1093/rheumatology/keae113.
Digitally supported shared decision-making and treat-to-target in rheumatology: a qualitative study embedded in a multicenter randomized controlled trial.
Muehlensiepen F, May S, Hadaschik K, Vuillerme N, Heinze M, Grahammer M, Labinsky H, Boeltz S, Detert J, Petersen J, Krönke G, Schett G, Knitza J.
Rheumatol Int. 2023 Apr;43(4):695-703
Care Bundle for Acute Kidney Injury in Cardiac Patients: A Cluster-Randomized Trial
Iwers R, Sliziuk V, Haase M, Barabasch S, Zänker M, Butter C, Haase-Fielitz A.
J Clin Med. 2023 Oct 6;12(19):6391. doi: 10.3390/jcm1219639
Eosinophilic fasciitis (Shulman syndrome) - recognition of the histological spectrum allows for new insights into possible pathomechanisms.
Pehl D, Preuße C, Allenbach Y, Benveniste O, Dittert P, Alten R, Krause A, Görl N, Zänker M, Goebel HH, Schneider U, Stenzel W.
Rheumatology (Oxford). 2023 May 2;62(5):2005-2014
Digitally supported shared decision-making and treat-to-target in rheumatology: a qualitative study embedded in a multicenter randomized controlled trial.
Muehlensiepen F, May S, Hadaschik K, Vuillerme N, Heinze M, Grahammer M, Labinsky H, Boeltz S, Detert J, Petersen J, Krönke G, Schett G, Knitza J.
Rheumatol Int. 2022 Oct 14
Progression of Chronic Kidney Disease and All-Cause Mortality in Patients with Tricuspid Regurgitation. Schipmann F, Bannehr M, Hähnel V, Dworok V, Nübel J, Edlinger C, Lichtenauer M, Haase M, Zänker M, Butter C, Haase-Fielitz A.
Diseases. 2022 Mar 16;10(1):16. doi: 10.3390
Eosinophilic fasciitis (Shulman syndrome) - recognition of the histological spectrum allows for new insights into possible pathomechanisms.
Pehl D, Preuße C, Allenbach Y, Benveniste O, Dittert P, Alten R, Krause A, Görl N, Zänker M, Goebel HH, Schneider U, Stenzel W.
Rheumatology (Oxford). 2022 Sep 20
Peripheral blood mononuclear cells are hypomethylated inactive rheumatoid arthritis and methylation correlates with disease activity
Liebold I, Grützkau A, Göckeritz A, Gerl V, Lindquist R, Feist E, Zänker M, Häupl T, Poddubnyy D, Zernicke J, Smiljanovic B, Alexander T, Burmester GR, Gay S, Stuhlmüller B
Rheumatology 2020;0:1–12
S2k Guidelines: Management of large-vessel vasculitis.
Schirmer JH, Aries PM, Balzer K, Berlit P, Bley TA, Buttgereit F, Czihal M, Dechant C, Dejaco C, Garske U, Henes J, Holle JU, Holl-Ulrich K, Lamprecht P, Nölle B, Moosig F, Rech J, Scheuermann K, Schmalzing M, Schmidt WA, Schneider M, Schulze-Koops H, Venhoff N, Villiger PM, Witte T, Zänker M, Hellmich B.
Z Rheumatol. 2020 Nov;79(Suppl 3):67-95.
Current Recommendations for Diagnostics in Giant Cell Arteritis
Bley T, Zänker M, Dechant C, Venhoff N.
Dtsch Med Wochenschr. 2019 May;144(9):587-594